Aiyaz Mohammed Musa Umarji, 48, pleaded guilty to importing $5 million of pseudoephedrine - a key ingredient to manufacture ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Zealand Pharma is working on the next-gen weight-loss treatment. Its Petrelintide showed promising results in a Phase 1b ...

Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

Zealand Pharma's CEO Adam Steensberg weighs in on early-stage trials of its obesity drug contender and talks down takeover ...